Instead, a combination of factors, including age at diagnosis, stage, tumor histology, tumor cell ploidy, and MYCN status, has been used to stratify patients into three pretreatment groups, low-, intermediate, and high-risk, according to The Children's Oncology Group (COG). Here, MYCN is linked to neoplasm.